Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human leukocyte antigen A*02 complexed with a peptide forms an essential part of cellular immunity. It enables cytotoxic T-cell recognition of infected or transformed cells through presentation of intracellularly derived antigens. Its prevalence makes it especially important clinically—for transplantation matching—and scientifically—as an archetype target in immunology research and therapeutic development.
Targeted by bispecific antibodies to redirect T-cells against cancer cells presenting specific peptide-HLA complexes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Leukocyte Antigen A*02 Complexed Peptide.